Sanofi

News

Sanofi extends Health2Sync digital diabetes partnership to J...

Digital health company Health2Sync will work with Sanofi on digitising its range of insulin products in Japan, extending an earlier alliance in other markets.

News

Takeda bolsters data for dengue jab as regulatory reviews ro...

Takeda has reported positive new, long-term results in its pivotal trial of dengue fever vaccine TAK-003 that builds the case for the shot as regulators review marketing applications.

News

Sanofi furthers its digital ambitions with Paris accelerator

Sanofi has launched a new initiative in its drive to integrate digital technologies throughout its business, setting up an accelerator based in Paris that will serve as the lynchpin of the

Market Access

Combination pricing: access to the future of oncology treatm...

Combination therapies are fast becoming the cornerstone of cancer treatment: not just in the UK, but across the world.

News

FDA grants speedy review to Dupixent rare skin disease

Sanofi and Regeneron should hear from the FDA in the autumn whether it will approve their blockbuster immunology drug Dupixent as a therapy for rare skin disease prurigo nodularis (PN).

News

SEC accuses former AstraZeneca exec of insider trading

The US Securities and Exchange Commission has sued a former AstraZeneca executive over alleged insider trading in connection with its 2019 deal to acquire rights to Daiichi Sankyo's breast

Sanofi extends Health2Sync digital diabetes partnership to J...

Takeda bolsters data for dengue jab as regulatory reviews ro...

Sanofi furthers its digital ambitions with Paris accelerator

Combination pricing: access to the future of oncology treatm...

FDA grants speedy review to Dupixent rare skin disease

SEC accuses former AstraZeneca exec of insider trading

Delivering the right behavioural ingredients for the moment,...

How to meet your physicians where they are online

Sanofi

Editor's Picks